(News Bulletin 247) – Jefferies initiates monitoring of Pfizer stock with a ‘hold’ recommendation and a price target of $43.
‘The lack of visibility keeps us on the sidelines,’ laments the analyst. While PFE’s long-term plans are ambitious (PFE bullish scenario: $78), Jefferies remains skeptical of their execution.
“We are at nearly $10 billion in adjusted revenue for 2030 from H1 24 launches versus $20 billion,” Jefferies continues, recalling being “below consensus on COVID revenue (nearly 9- $12 billion versus $13-15 billion)’.
Copyright (c) 2023 News Bulletin 247. All rights reserved.
I have over 8 years of experience working in the news industry. I have worked as a reporter, editor, and now managing editor at 247 News Agency. I am responsible for the day-to-day operations of the news website and overseeing all of the content that is published. I also write a column for the website, covering mostly market news.
